|
Medical Device Companies Gear Up To Make
Kits To Test Monkeypox
Synopsis
The company said its experts have developed "POX-Q Multiplexed RT-PCR kit" for
the detection of the novel virus along with differentiation from varicella
zoster virus (chickenpox) in a single-tube multiplex reaction format.
Gurgaon-based Genes2Me on Tuesday said it has developed a test to detect the
Monkeypox virus, joining a clutch of companies that have developed diagnostic
kits to help contain the virus' flare-up in regions where it was not found
earlier. Genes2Me said its real-time PCR-based kit for quick detection of
Monkeypox virus has a turnaround time of less than 50 minutes.
The company said its experts have developed "POX-Q Multiplexed RT-PCR kit" for
the detection of the novel virus along with differentiation from varicella
zoster virus (chickenpox) in a single-tube multiplex reaction format. Another
company, Punebased Mylab Discovery Solutions, is also developing a test kit for
monkeypox. Last month, medical devices company Trivitron Healthcare announced
that it has developed a real-time PCRased kit for detection of the monkeypox
virus.
"India has always been at the forefront of extending help to the world,
especially during the Covid-19 pandemic, and this time also the world needs
assistance," Trivitron Healthcare Group chief executive officer Chandra Ganjoo
said in a statement. The company said diagnostic tools are crucial, along with
response measures to control the spread of the virus and deal with emerging
public health challenges.
"Trivitron's monkeypox real-time PCR kit is a four -colour fluorescence-based
kit, which can differentiate between smallpox and Monkeypox in a one-tube
single-reaction format, with a total turnaround time of one hour," it said.
https://economictimes.indiatimes.com/industry/healthcare/biotech/
pharmaceuticals/medical-device-companies-gear-up-tomake-kits-to-test-the-new-threat/articleshow/93146168.cms
(Jul 27, 2022)
Wipro GE Healthcare, Boston Scientific
Join Hands To Provide Cardiac Care Solutions In India
Synopsis
The first of its kind collaboration between the two global medtech companies in
India, will offer advanced medical devices and capabilities from Boston
Scientific, coupled with GE Healthcare’s strong medical imaging systems like
cardiac catherization lab and related software, support diagnostics through
treatment and monitoring of the cardiac patient-care pathway.
Wipro GE Healthcare on Tuesday said it has joined hands with medical device
maker Boston Scientific, to provide end-to-end innovative interventional cardiac
care solutions in India.
The first of its kind collaboration between the two global medtech companies in
India, will offer advanced medical devices and capabilities from Boston
Scientific, coupled with GE Healthcare’s strong medical imaging systems like
cardiac catherization lab and related software, support diagnostics through
treatment and monitoring of the cardiac patient-care pathway.
Wipro GE Healthcare said the collaboration will enable easier access to
treatment and is intended to improve heart care for patients, thereby addressing
the disease burden prevailing in the country.
The companies will also work collectively support the training and education of
healthcare professionals and raise consumer awareness about the impact of
vascular imaging advancements within cardiac catherization procedures, thus
enabling better patient outcomes. Earlier this year, GE Healthcare signed a
similar partnership with Boston Scientific in Southeast Asia which also offers
combined cardiology solutions to customers including in training and education.
“End-to-end cardiac care centres, with a focus on best-in-class patient outcomes
are fundamental in bridging the industry gap and managing cardiac burden in
India," said Dr. Shravan Subramanyam, MD, of Wipro GE Healthcare.
"It’s essential to work with clinicians and healthcare providers to understand
the challenges they face in care delivery, and to provide tailored solutions to
help them manage those obstacles and better serve their patients,” said Manoj
Madhavan, MD of Boston Scientific in India.
“This collaboration is focused on addressing such challenges by providing
healthcare professionals expanded access to the latest solutions and
technologies to advance patient care.”
https://economictimes.indiatimes.com/industry/healthcare/ |
